checkAd

     169  0 Kommentare Allena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock Split - Seite 3

    Investor Relations Contact:
    Email: info@allenapharma.com
    Phone: 617-467-4577
    Fax: 617-916-1871


    Lesen Sie auch


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3
    Verfasst von globenewswire
    Allena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock Split - Seite 3 NEWTON, Mass., July 05, 2022 (GLOBE NEWSWIRE) - Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare …